Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings has fallen about 40.9% over the past five years, yet on current checks the stock still screens as undervalued, which raises the question of whether sentiment has swung harder than the fundamentals justify. The share price decline of roughly 40.9% over five years signals ...

Zimmer Biomet Holdings (ZBH) is back in focus after recent commentary around its cementless implants and ROSA robotic-assisted surgery platform, along with plans to expand further into upper extremities and foot and ankle categories. See our latest analysis for Zimmer Biomet Holdings.

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating the Potential 12.84% Upside in the Healthcare Sector

ZBH offers a more balanced risk profile, with dependable earnings growth and margin expansion driven by operational discipline. Its upside potential appears comparatively constrained, given its mature and diversified business mix. The company currently trades at P/E F12M ratio of 10.08X, below ...

Zillow Group stock has given up a large amount of value over the past few years, yet current valuation checks still suggest the shares are not a clear bargain. After a sharp five year decline, the stock now carries a low value score and trades on multiples that screen as expensive.